Aghabozorgi AS, Bahreyni A, Soleimani A, Bahrami A, Khazaei M, Ferns GA, Avan A, Hassanian SM
Discuss with your provider any history of pancreatitis or severe digestive issues to explore alternative treatments
(2016) found that the GLP-1RAs exendin-4 and liraglutide could improve oxidative stress and cognitive dysfunction caused by middle cerebral artery occlusion in diabetic mice and could reduce the production of reactive oxygen species and the expression of related inflammatory proteins in the brain and blood
Acknowledgements This study was supported by NSFC 82401072
These medications are powerful tools, but they are not right for everyone
(Source: Drug Discovery Trends, November 2025) Market Projected to Reach $115.9 Billion by 2030 The global tirzepatide market is projected to grow from $482.5 million in 2022 to $115.9 billion by 2030 a compound annual growth rate (CAGR) of 40.17%